165 related articles for article (PubMed ID: 35939174)
1. Clinical significance of circulating neutrophils and lymphocyte subsets in newly diagnosed patients with diffuse large B-cell lymphoma.
Yang Z; Yu W
Clin Exp Med; 2023 Jul; 23(3):815-822. PubMed ID: 35939174
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Impact of Peripheral Blood T-Cell Subsets at the Time of Diagnosis on Survival in Patients with Diffuse Large B-Cell Lymphoma.
Shin HJ; Kim DY; Chung J; Shin KH; Lee H
Acta Haematol; 2021; 144(4):427-437. PubMed ID: 33271543
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil/Lymphocyte Ratio, Lymphocyte/Monocyte Ratio, and Absolute Lymphocyte Count/Absolute Monocyte Count Prognostic Score in Diffuse Large B-Cell Lymphoma: Useful Prognostic Tools in the Rituximab Era.
Ho CL; Lu CS; Chen JH; Chen YG; Huang TC; Wu YY
Medicine (Baltimore); 2015 Jun; 94(24):e993. PubMed ID: 26091479
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil to lymphocyte ratio improves prognostic prediction of International Prognostic Index for patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone.
Keam B; Ha H; Kim TM; Jeon YK; Lee SH; Kim DW; Kim CW; Heo DS
Leuk Lymphoma; 2015 Jul; 56(7):2032-8. PubMed ID: 25382617
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of absolute lymphocyte/monocyte ratio, red cell distribution width and neutrophil/ lymphocyte ratio in diffuse large B-cell lymphoma patients.
Hasan KM; Elmeshhedany AY
Cell Mol Biol (Noisy-le-grand); 2021 Nov; 67(3):61-68. PubMed ID: 34933732
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of pretreatment neutrophil-lymphocyte ratio in patients with diffuse large B-cell lymphoma treated with RCHOP.
Wang J; Zhou M; Xu JY; Yang YG; Zhang QG; Zhou RF; Chen B; Ouyang J
Medicine (Baltimore); 2016 Sep; 95(38):e4893. PubMed ID: 27661033
[TBL] [Abstract][Full Text] [Related]
7. The impact of the neutrophil:lymphocyte ratio in response and survival of patients with de novo diffuse large B-cell lymphoma.
Beltrán BE; Paredes S; Cotrina E; Sotomayor EM; Castillo JJ
Leuk Res; 2018 Apr; 67():82-85. PubMed ID: 29477024
[TBL] [Abstract][Full Text] [Related]
8. Peripheral blood lymphocyte subsets of newly diagnosed DLBCL patients and their dynamic changes with rituximab based immunochemotherapy.
Yang Z; Yu W; Wang S; Zhou X; Liu S; Ma S
Leuk Lymphoma; 2019 Dec; 60(12):2909-2916. PubMed ID: 31120360
[TBL] [Abstract][Full Text] [Related]
9. A new prognostic model using the NCCN-IPI and neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma.
Go SI; Park S; Kim JH; Kim HR; Kim M; Moon K; Seo J; Lee GW
Tumori; 2018 Aug; 104(4):292-299. PubMed ID: 29737944
[TBL] [Abstract][Full Text] [Related]
10. [Change of Neutrophils/ Lymphocyte Ratio in Patients with DLBCL before and after CHOP or R-CHOP Chemotherapy and Its Effect on Survival of Patients].
Li JD; Han XL; Yang C; Sun L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb; 26(1):182-186. PubMed ID: 29397840
[TBL] [Abstract][Full Text] [Related]
11. Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2-3 diffuse large B-cell lymphoma.
Plonquet A; Haioun C; Jais JP; Debard AL; Salles G; Bene MC; Feugier P; Rabian C; Casasnovas O; Labalette M; Kuhlein E; Farcet JP; Emile JF; Gisselbrecht C; Delfau-Larue MH;
Ann Oncol; 2007 Jul; 18(7):1209-15. PubMed ID: 17496307
[TBL] [Abstract][Full Text] [Related]
12. [Comparison the efficacy and prognosis of different first-line treatment for elderly diffuse large B-cell lymphoma].
Liu P; Jiang SY; He XH; Qin Y; Gui L; Zhou SY; Yang JL; Yang S; Wen TY; Shi YK
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):234-241. PubMed ID: 32252203
[No Abstract] [Full Text] [Related]
13. An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era.
Sun F; Zhu J; Lu S; Zhen Z; Wang J; Huang J; Ding Z; Zeng M; Sun X
BMC Cancer; 2018 Jan; 18(1):5. PubMed ID: 29291712
[TBL] [Abstract][Full Text] [Related]
14. Dynamic changes in peripheral blood lymphocyte subset counts and functions in patients with diffuse large B cell lymphoma during chemotherapy.
Hou H; Luo Y; Tang G; Zhang B; Ouyang R; Wang T; Huang M; Wu S; Li D; Wang F
Cancer Cell Int; 2021 May; 21(1):282. PubMed ID: 34044841
[TBL] [Abstract][Full Text] [Related]
15. Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large B-cell lymphoma in the rituximab era.
Watanabe R; Tomita N; Itabashi M; Ishibashi D; Yamamoto E; Koyama S; Miyashita K; Takahashi H; Nakajima Y; Hattori Y; Motohashi K; Takasaki H; Ohshima R; Hashimoto C; Yamazaki E; Fujimaki K; Sakai R; Fujisawa S; Motomura S; Ishigatsubo Y
Eur J Haematol; 2014 Mar; 92(3):204-10. PubMed ID: 24283206
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Significance of Pretreatment Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Patients with Diffuse Large B-Cell Lymphoma.
Wang S; Ma Y; Sun L; Shi Y; Jiang S; Yu K; Zhou S
Biomed Res Int; 2018; 2018():9651254. PubMed ID: 30643825
[TBL] [Abstract][Full Text] [Related]
17. Predicting survival for diffuse large B-cell lymphoma patients using baseline neutrophil/lymphocyte ratio.
Porrata LF; Ristow K; Habermann T; Inwards DJ; Micallef IN; Markovic SN
Am J Hematol; 2010 Nov; 85(11):896-9. PubMed ID: 20842639
[TBL] [Abstract][Full Text] [Related]
18. Peripheral blood cell ratios as prognostic factors in canine diffuse large B-cell lymphoma treated with CHOP protocol.
Henriques J; Felisberto R; Constantino-Casas F; Cabeçadas J; Dobson J
Vet Comp Oncol; 2021 Jun; 19(2):242-252. PubMed ID: 33247533
[TBL] [Abstract][Full Text] [Related]
19. The neutrophil-lymphocyte ratio and immunosuppressive acidic protein may be useful parameters for predicting depression among middle-aged patients with diffuse large B cell lymphoma.
Yi K; Lan H; Zhang Y; Liu L; Jin S; Mou X; Xian H; Li R
Ann Palliat Med; 2021 Mar; 10(3):3299-3306. PubMed ID: 33849114
[TBL] [Abstract][Full Text] [Related]
20. Peripheral blood T cell alterations in newly diagnosed diffuse large B cell lymphoma patients and their long-term dynamics upon rituximab-based chemoimmunotherapy.
Battella S; Cox MC; La Scaleia R; Di Napoli A; Di Landro F; Porzia A; Franchitti L; Mainiero F; Ruco L; Monarca B; Santoni A; Palmieri G
Cancer Immunol Immunother; 2017 Oct; 66(10):1295-1306. PubMed ID: 28555258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]